Susan M. Langan-Fahey

Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient.

S P Robinson, Susan M. Langan-Fahey, D A Johnson et al. · Drug Metabolism and Disposition · 1991 · 275 citations

Medicine, Pharmacokinetics, Pharmacology +12

Alteration of Endocrine Parameters in Premenopausal Women With Breast Cancer During Long-Term Adjuvant Therapy With Tamoxifen as the Single Agent

V. Craig Jordan, Nancy F. Fritz, Susan M. Langan-Fahey et al. · JNCI Journal of the National Cancer Institute · 1991 · 153 citations

Medicine, Endocrinology, Oncology +16

Suppression of Mouse Mammary Tumorigenesis by Long-Term Tamoxifen Therapy

V. Craig Jordan, Mary K. Lababidi, Susan M. Langan-Fahey · JNCI Journal of the National Cancer Institute · 1991 · 136 citations

Medicine, Endocrinology, Oncology +10

Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancer

Susan M. Langan-Fahey, Douglass C. Tormey, V. Craig Jordan · European Journal of Cancer and Clinical Oncology · 1990 · 119 citations

Medicine, Oncology, Pharmacology +16

Investigation of the Mechanism of Tamoxifen-Stimulated Breast Tumor Growth With Nonisomerizable Analogues of Tamoxifen and Metabolites

Danny Wolf, Susan M. Langan-Fahey, Christopher Parker et al. · JNCI Journal of the National Cancer Institute · 1993 · 93 citations

Medicine, Oncology, Pharmacology +17